Cataract surgery and diabetes

Current Opinion in Ophthalmology

Volumn 21, Issue 1, 2010, Pages 4-9

  Shah, Ankoor S ^a   Chen, Sherleen H ^b  

^a Eye Trauma Service   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bevacizumab; Cataract surgery; Diabetic retinopathy; Macular edema; Panretinal photocoagulation; Triamcinolone 2010 wolters kluwer health

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; MONOCLONAL ANTIBODY; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN A;

CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; IMMUNOTHERAPY; LASER COAGULATION; OUTCOME ASSESSMENT; PHACOEMULSIFICATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; VISUAL ACUITY; DRUG ANTAGONISM; PATHOPHYSIOLOGY; RETINA MACULA EDEMA;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; LASER COAGULATION; MACULAR EDEMA; PHACOEMULSIFICATION; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 75549090491     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328333e9c1     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. In Edited by Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. pp. 1-14.
2. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995; 119: 295-300.
3. Mozaffarieh M, Heinzl H, Sacu S, et al Second eye cataract surgery in the diabetes patient? Quality of life gains and speed of visual and functional rehabilitation. Ophthalmic Res 2009; 41: 2-8.
4. Bonillo JL, Mittra RA, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Trans Am J Ophthalmol Soc 1999; 97: 435-449.
5. Kato S, Fukada Y, Hon S, et al. Influence of phacoemulsification and intraocular lens implantation on the course of diabetic retinopathy. J Cataract Refract Surg 1999; 25: 788-793.
6. Mittra RA, Bonillo JL, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 2000; 118: 912-917.
7. Zaczek A, Olivestedt G, Zetterstrom C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol 1999; 83: 1036-1041. (Pubitemid 29433425)
8. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 1999; 117: 1600-1606.
9. Dowler JG, Sehmi KS, Hykin PG, et al. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999; 106: 663-668.
10. ldeta R, Yamashita H, Tanaka Y, et al. Roles of cytokines in diabetic retinopathy. Arch Ophthalmol 1999; 117: 700-701.
11. Bhagat N, Grigorian RA, Tutela A, et al. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009; 54: 1-32.
12. Jaffe GJ, Burton TC, Kuhn E, et al. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992; 114: 448-456.
13. Minassian DC, Rosen P, Dart JK, et al. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Br J Ophthalmol 2001 ; 85: 822-829.
14. Dowler JG, Hykin PG, Hamilton AM. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology 2000; 107: 457-462. (Pubitemid 30191365)
15. Krepier K, Biowski R, Schrey S, et al. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2002; 240: 735-738. (Pubitemid 36097101)
16. Squirrell D, Bhola R, Bush J, A et al. prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 2002; 86: 565-571. (Pubitemid 34454505)
17. Romero-Aroca P, Femandez-Ballart J, et al. Almena-Garcia M,. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J Cataract Refract Surg 2006; 32: 1438-1444. (Pubitemid 44262475)
18. Hong T, Mitchell P, de Loryn T, et al. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology 2009; 116: 1510-1514.
19. Biro Z, Balla Z. OCT measurements on the foveal and penfoveal retinal thickness on diabetic patients after phacoemulsification and IOL implantation. Eye (in press), doi 10.1038/eye.2009. 164.
20. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007; 114: 881-889. (Pubitemid 46635831)
21. Henricsson M, Heijl A, Janzon L Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996; 80: 789-793.
22. Fraser-Bell S, Kaines A, Hykin PG. Update on treatments for diabetic macular edema. Curr Opin Ophthalmol 2008; 19: 185-189.
23. Kim SY, Yang J, Lee YC, et al Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery. J Cataract Refract Surg 2008; 34: 823-826.
24. Cheema RA, Al-Mubarak MM, Amin YM, et al. Role of combined cataract surgery and intravltreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J Cataract Refract Surg 2009; 35: 18-25.
25. Chen CH, Liu YC, Wu PC. The combination of intravitreal bevacizumab and phacoemulsification surgery In patients with cataract and coexisting diabetic macular edema. J Ooul Pharmacol Ther 2009; 25: 83-89.
26. Lanzagorta-Arestl A, Palacios-Pozo E, Menezo Rozalen JL, et al. Prevention of vision loss after cataract surgery in diabetic macular edema with ntravitreal bevacizumab: a pilot study. Retina 2009; 29: 530-535.
27. Takamura Y, Kubo E, Akagi Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology 2009; 116: 1151-1157.
28. Beck RW, Edwards AR, Aiello LP, ei al. Three-year follow-up of a randomlzed trial comparing focal/grid photocoagulation and ntravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009; 127: 245-251.
29. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing ntravitreal triamcinolone acetonlde and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008; 115:1447-1449, 1449. e1-10.
30. Suto C, Hon S, Kato S. Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery. J Cataract Refract Surg 2008; 34: 1001-1006. (Pubitemid 351685636)